English abstract
COVID-19 is a severe respiratory disease with a spectrum of clinical presentations
and complications. Warm autoimmune hemolytic anemia (WAIHA) is increasingly
recognized in patients with COVID-19 either while infected or shortly after infection.
We report a 36-year-old male with clinical and laboratory findings consistent with
WAIHA. His medical history was significant for COVİD-19 infection three months
before presentation. He was initially resistant to steroids but had substantial improvement
following initiation of rituximab, with complete recovery thereafter. Therefore, serial
assessment of complete blood cell count parameters and hemolysis markers post COVID-19 infections is warranted for early detection and prompt treatment.
